Equities

Acme United Corp

Acme United Corp

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Acme United Corporation is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. It markets and sells through two main product categories: first aid and medical and cutting and sharpening. The first aid and medical category includes first aid and safety products, such as First Aid Only, PhysiciansCare, Pac-Kit, Spill Magic, First Aid Central, Med-Nap and Safety Made brands. Its cutting and sharpening categories include school, home and office products (Westcott brand). Brands under hardware, industrial and sporting goods products are Clauss and DMT. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, and sharpening tools. It is also a supplier of tactical, trauma and emergency response products. It sells its products to mass market and e-commerce retailers, wholesale, contract and retail stationery distributors, and hardware chains.

  • Revenue in USD (TTM)190.62m
  • Net income in USD18.44m
  • Incorporated1882
  • Employees645.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ACU:ASQ since
announced
Transaction
value
Hawktree Solutions Inc-Selected AssetsDeal completed27 Sep 202327 Sep 2023Deal completed37.92%1.00m
Data delayed at least 15 minutes, as of May 24 2024 21:10 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.